Ataluren
Ataluren
Ataluren (pronounced as: ah-TAL-uh-ren) is a pharmaceutical drug used in the treatment of Duchenne muscular dystrophy (DMD) and nonsense mutation cystic fibrosis. It is marketed under the trade name Translarna.
Etymology
The name "Ataluren" is derived from the phrase "ataluren the nonsense", which refers to the drug's mechanism of action in overcoming nonsense mutations in genetic disorders.
Mechanism of Action
Ataluren works by allowing the cell's protein-making machinery to skip over the mutation, enabling the production of a functional protein. This process is known as read-through.
Usage
Ataluren is used in the treatment of Duchenne muscular dystrophy and cystic fibrosis caused by nonsense mutations. It is taken orally, usually three times a day.
Side Effects
Common side effects of Ataluren include headache, nausea, vomiting, and fatigue. More serious side effects may include kidney damage.
Related Terms
External links
- Medical encyclopedia article on Ataluren
- Wikipedia's article - Ataluren
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski